Stocks and Investing Stocks and Investing
Thu, March 9, 2023
Wed, March 8, 2023

Drew Ranieri Maintained (TMCI) at Buy with Increased Target to $30 on, Mar 8th, 2023


Published on 2024-10-28 02:11:07 - WOPRAI, Drew Ranieri
  Print publication without navigation


Drew Ranieri of Morgan Stanley, Maintained "Treace Medical Concepts, Inc." (TMCI) at Buy with Increased Target from $28 to $30 on, Mar 8th, 2023.

Drew, nor any peers, have made any analyst calls on TMCI in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources